María M Tejero-Ojeda - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Progress in Neurobiology|March 2, 2025

Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovationsPaula López-García, María M Tejero-Ojeda, María Eugenia Vaquero, et al.

ACS Synthetic Biology|December 1, 2021

Conversion of the OmpF Porin into a Device to Gather Amyloids on the E. coli Outer MembraneSol Vendrell-Fernández, Paloma Lozano-Picazo, Paula Cuadros-Sánchez, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 22, 2026

QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro StudyMaría M Tejero-Ojeda, Ada Bernaus Vives, Michał Wojciechowski, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Progress in Neurobiology|March 2, 2025

Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovationsPaula López-García, María M Tejero-Ojeda, María Eugenia Vaquero, et al.

ACS Synthetic Biology|December 1, 2021

Conversion of the OmpF Porin into a Device to Gather Amyloids on the E. coli Outer MembraneSol Vendrell-Fernández, Paloma Lozano-Picazo, Paula Cuadros-Sánchez, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 22, 2026

QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro StudyMaría M Tejero-Ojeda, Ada Bernaus Vives, Michał Wojciechowski, et al.

Pageof 1